Abstract
At present major issues regarding optimal therapy of acute nonlymphocytic leukemia (ANLL) remain unresolved. Controversial areas include the importance of consolidation and the role of postconsolidation therapy (either conventional or intensive). To investigate these problems the Italian Cooperative Group GIMEMA designed a prospective treatment program based on standard induction therapy with daunorubicin (DNR) plus cytosine arabinoside (Ara-C) followed by intensive consolidation. There-after, patients were randomized in three arms to receive an aggressive postconsolidation treatment with sequential combinations of active agents given in short courses at myelosuppressive doses, conventional maintenance, or no treatment at all. This multi- center trial began in 1982 and was closed to patient entry in May 1987.
Supported in part by a grant from the Italian National Research Council, Special Project “Oncology” CNR No. 87.02801.44, CNR No. 87.01494.04, and MPI 40%
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bennett JM, Catovsky D, Daniel MT et al. (1976) Proposals for the classification of the acute leukemias. French-American-British ( FAB) Co-operative group. Br J Haematol 33: 451–458
Kaplan EL, Meier P (1958) Non-parmaetric estimation from incomplete observations. J Am Stat Assoc 53: 457–481
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163–170
Cox DR (1972) Regression models and life- tables (with discussion). J R Stat Soc 34: 187–220
Rees JKH, Gray GR, Swirsky D et al. (1986) Principal results of the medical research coun-cil’s 8th acute myeloid leukaemia trial. Lancet 29: 1236–1241
Vogler WR, Winton EF, Gordon DS et al. (1984) A randomised comparison of post-re- mission therapy in acute myelogenous leukemia. A Southeastern cancer study group trial. Blood 63: 1039–1045
Sauter CHR, Berchtold W, Fopp M et al. (1984) Acute myelogenous leukemia: maintenance chemotherapy after early consolidation treatment does not prolong survival. Lancet 18: 379–382
Weinstein HJ, Mayer RJ, Rosenthal DS et al. (1983) Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315–319
Preisler HP, Davis RB, Kirshner J et al. (1987) Comparison of three remission induction regimens and two post-induction strategies for the treatment of acute non lymphocytic leukemia: a cancer and Leukemia Group B Study. Blood 69: 1441–1449
Cassileth PA, Begg CB, Bennett JM et al. (1984) A randomized study of the efficacy of consolidation therapy in adult acute non lymphocytic leukemia. Blood 63: 843–847
Büchner TH, Urbanitz D, Hiddemann W et al. (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Co-operative Group. J Clin Oncol 3: 1583–1589
Mayer RJ, Ferreira PPC, Cuttner J et al. (1980) Central nervous system involvement at presentation in acute granulocytic leukemia: a prospective cytocentrifuge study. Am J Med 68: 691–694
Stewart DJ, Keating MJ, Mc Kredie KB et al. (1981) Natural history of central nervous sys-tem acute leukemia. Cancer 47: 184–196
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Petti, M.C. et al. (1990). Therapy of Acute Myelogenous Leukemia in Adults. In: Büchner, T., Schellong, G., Hiddemann, W., Ritter, J. (eds) Acute Leukemias II. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74643-7_45
Download citation
DOI: https://doi.org/10.1007/978-3-642-74643-7_45
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-50984-4
Online ISBN: 978-3-642-74643-7
eBook Packages: Springer Book Archive